• 1. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 2. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 3. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 4. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 5. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Primary amines

Introduction to 1-Hexanamine, hydrobromide (CAS No. 7334-95-4)

1-Hexanamine, hydrobromide, with the chemical formula C?H??BrN·HBr, is a well-documented compound in the field of organic chemistry and pharmaceutical research. This compound, identified by its CAS number 7334-95-4, has garnered significant attention due to its versatile applications in synthetic chemistry and its potential role in the development of novel bioactive molecules. The hydrobromide salt form enhances its solubility in aqueous systems, making it a valuable intermediate in various chemical processes.

The structure of 1-Hexanamine, hydrobromide consists of a hexyl chain attached to an amine group, with the presence of a bromide counterion. This configuration imparts unique chemical properties that make it useful in cross-coupling reactions, peptidomimetic synthesis, and as a precursor for more complex molecules. In recent years, advancements in synthetic methodologies have further highlighted the importance of this compound in medicinal chemistry.

One of the most compelling aspects of 1-Hexanamine, hydrobromide is its role in the synthesis of pharmacologically active agents. Researchers have leveraged its reactivity to develop novel compounds with potential therapeutic applications. For instance, studies have demonstrated its utility in constructing peptidomimetics that mimic the biological activity of natural peptides while exhibiting improved pharmacokinetic profiles. These peptidomimetics are particularly relevant in the treatment of inflammatory diseases and cancer.

Recent research has also explored the use of 1-Hexanamine, hydrobromide in the development of small-molecule inhibitors targeting specific enzymatic pathways. By modifying its structure, chemists have been able to create derivatives with enhanced binding affinity and selectivity. Such inhibitors are crucial in drug discovery, as they can modulate biological processes at the molecular level. For example, derivatives of 1-Hexanamine, hydrobromide have shown promise in inhibiting kinases involved in signal transduction pathways associated with neurological disorders.

The compound's versatility extends to material science applications as well. Its ability to act as a building block for more complex molecules has made it valuable in polymer chemistry and nanotechnology. Researchers have utilized 1-Hexanamine, hydrobromide to synthesize functionalized polymers that exhibit unique properties such as biodegradability and stimuli-responsive behavior. These materials are being explored for use in drug delivery systems and smart materials.

In conclusion, 1-Hexanamine, hydrobromide (CAS No. 7334-95-4) is a multifaceted compound with significant implications across multiple scientific disciplines. Its role in pharmaceutical research, particularly in the development of bioactive molecules and peptidomimetics, underscores its importance. As synthetic chemistry continues to evolve, the applications of 1-Hexanamine, hydrobromide are expected to expand further, driving innovation in drug discovery and material science.

• 352438-81-4(n-Hexyl-d13-amine)
• 646-19-5(Heptane-1,7-diamine)
• 646-24-2(1,9-Diaminononane)
• 646-25-3(1,10-Diaminodecane)
• 14846-47-0(N-Octylamine hydrobromide)
• 26204-55-7(1-Dodecanamine, hydrobromide)
• 24731-81-5(1,6-Hexanediamine,hydrobromide (1:2))
• 149698-79-3(Octanamine (9CI))
• 14130-06-4(1-Docosanamine)
• 14130-05-3(1-Aminononadecane)